Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Administrative Law (3)
- Business Organizations Law (2)
- Environmental Sciences (2)
- Food and Drug Law (2)
- Life Sciences (2)
-
- Natural Resource Economics (2)
- Natural Resources Law (2)
- Natural Resources Management and Policy (2)
- Natural Resources and Conservation (2)
- Physical Sciences and Mathematics (2)
- Public Affairs, Public Policy and Public Administration (2)
- Social and Behavioral Sciences (2)
- Antitrust and Trade Regulation (1)
- Biodiversity (1)
- Communications Law (1)
- Environmental Law (1)
- Environmental Policy (1)
- Forest Management (1)
- Forest Sciences (1)
- Indigenous, Indian, and Aboriginal Law (1)
- Intellectual Property Law (1)
- Internet Law (1)
- Land Use Law (1)
- Law and Economics (1)
- Property Law and Real Estate (1)
- Public Administration (1)
- Public Policy (1)
- Recreation, Parks and Tourism Administration (1)
- Science and Technology Law (1)
- Publication
- Publication Type
Articles 1 - 5 of 5
Full-Text Articles in Law
A Shadow Government: Private Regulation, Free Speech, And Lessons From The Sinclair Blogstorm, Marvin Ammori
A Shadow Government: Private Regulation, Free Speech, And Lessons From The Sinclair Blogstorm, Marvin Ammori
Michigan Telecommunications & Technology Law Review
Because of the economics of online information, thousands who do not know each other can band together in hours, without previous organizational coordination or any persistent central coordination, to affect others and conform society to their idea of the social good. This changes the dynamic of political action and the ability of unaffiliated, lone individuals to respond to social acts where government and the market have not. Through ad hoc volunteerism, the Sinclair participants produced regulatory action against a private party with whom they were not transacting--because they believed government failed to do so. Although ad hoc volunteerism has received …
Day 1: Wednesday, 17 August 2005: Biodiversity And Critical Habitat, Charles Bedford, Federico Cheever, Tim Sullivan
Day 1: Wednesday, 17 August 2005: Biodiversity And Critical Habitat, Charles Bedford, Federico Cheever, Tim Sullivan
Endangered Species Act Congressional Field Tour (August 17-19)
6 pages (includes color illustration).
Contains references.
Slides: A Fine Line Between Success And Failure In Partnerships, Greg Neudecker
Slides: A Fine Line Between Success And Failure In Partnerships, Greg Neudecker
Community-Owned Forests: Possibilities, Experiences, and Lessons Learned (June 16-19)
Presenter: Greg Neudecker, U.S. Fish and Wildlife Service, Great Falls, MT
48 slides
The Problem Of New Uses, Rebecca S. Eisenberg
The Problem Of New Uses, Rebecca S. Eisenberg
Articles
Discovering new uses for drugs that are already on the market seems like it ought to be the low-lying fruit of biopharmaceutical research and development (R&D). Firms have already made significant investments in developing these drugs and bringing them to market, including testing them in clinical trials, shepherding them through the FDA regulatory approval process, building production facilities, and training sales staff to market them to physicians. By this point, the drugs have begun to enjoy goodwill among patients and physicians and casual observations in the course of clinical experience may point to potential new uses. One might expect that …
Learning The Value Of Drugs - Is Rofecoxib A Regulatory Success Story?, Rebecca S. Eisenberg
Learning The Value Of Drugs - Is Rofecoxib A Regulatory Success Story?, Rebecca S. Eisenberg
Articles
Controversy over recent revelations concerning the adverse cardiovascular effects of selective cyclooxygenase- 2 (COX-2) inhibitors has generally been framed as a story of regulatory failure, in which the Food and Drug Administration (FDA) has failed in its mission to protect the public from unsafe products. But this simplistic understanding of the mission of the FDA seems to make failure all but inevitable, if the reliable observation of the risks and benefits of a drug requires rigorous long-term studies. Perhaps in an earlier era the goal of drug regulation was simply to protect the public from poisons. Today, drug regulation guides …